Background: Prostate cancer (PCa) bone metastasis can be markedly enhanced by increased receptor activator of NF kappa-B ligand (RANKL) expression in PCa cells. Molecular mechanisms that account for the increased predilection of PCa for bone include increased bone turnover, promotion of PCa cell growth and survival in the bone environment, and recruitment of bystander dormant cells to participate in bone metastasis. The current study tests the hypothesis that PCa cells acquire high adhesion to bone matrix proteins, which controls PCa bone colonization, under the RANKL/ RANK and AR axes.
Introduction
Prostate cancer (PCa) has the highest incidence and is the second most common cause of cancer death among men in western countries [1] . The main clinical complication causing morbidity [2, 3] and mortality in PCa patients is bone metastasis, which presents in over 80% of all men who die of PCa [4, 5] . Despite the high occurrence of skeletal metastasis, the underlying molecular mechanisms determining the predilection of PCa cells for homing to bone are not well-understood. Previously, we hypothesized that the osteomimetic properties of PCa cells account for the predilection of PCa to metastasize and grow in the bone microenvironment [6] . We found that β-2 microglobulin (β-2 M), a major histocompatibility co-receptor, mediates the expression of non-collagenous bone matrix proteins such as osteocalcin and bone sialoprotein in metastatic human prostate cancer cell lines [7] . We found that upon the induction of β-2 M, prostate cancer cells overexpress RANKL, a protein intimately related physiologically to bone turnover [8] . RANKL drives PCa cells to undergo epithelial-to-mesenchymal transition (EMT) [9, 10] , and when expressed by human cancer cell lines like LNCaP RANKL , produces explosive skeletal and soft tissue metastases upon intracardiac administration in mice [11] .
Overexpression of RANKL plays a role in the breast cancer osteolytic phenotype by binding to its RANK receptor on precursor osteoclasts [12] . Recent studies have shown that RANKL positively correlates with higher Gleason score in PCa [13] and predicts the survival of PCa patients [14] . Denosumab, an anti-RANKL antibody approved by the FDA for the management of osteoporosis and breast and prostate cancer bone metastasis, has been shown to improve or delay skeletal metastasis in breast and prostate cancer by 35% [15] and 18% [16] , respectively. However, overall patient survival is not affected, indicating the critical roles of other potential factors affected by the RANK-mediated downstream signaling network in PCa bone metastasis.
Another important factor in the development and progression of PCa is androgen receptor (AR) [17] . AR has regulatory roles promoting PCa cell adhesion and survival in bone. PCa cells are initially androgen-sensitive (AS) and respond to androgen deprivation therapy (ADT) [17] . Overtime, while PCa cells remain AR positive, they progress to become androgen-insensitive (AI) and acquire increased invasiveness and metastatic potential [18, 19] . AI tumors in hosts subjected to ADT become hypersensitive to residual intracrine androgen due in part to AR gene amplification, AR gene mutation, and/or higher AR regulating transcription factors (TFs) [20] [21] [22] . Recently, AR was found to induce cancer cell adhesion and survival through integrin expression [23] [24] [25] . Since AR plays a significant role in PCa metastasis, understanding how AR affects PCa adhesion to collagen matrix in bone could provide potential therapeutic approaches to block PCa bone homing and increase patient survival.
Multivariable tumor and microenvironmental factors are known to engage in tumor development and progression. Current 2-D monolayer culture lacks the relevant cell-cell and cell-matrix interactions that occur physiologically in the in vivo environment. This limitation makes it extremely difficult or potentially impossible to define the key cell signaling networks supporting essential cellular functions in vitro [26, 27] . Extracellular matrix (ECM) mediates biological and physical cues external to the cell that result in altered cell proliferation, migration, invasion, and adhesion. Cell-ECM communication is initiated through the interaction of α-and β-integrin subunits to specific extracellular matrices [28, 29] activating cell signaling pathways such as cell focal adhesion kinase (FAK) [30, 31] . 3-D in vitro models have an invaluable ability to recapitulate some of the in vivo cell-cell and cell-ECM interactions governing tumor cell behavior [32, 33] .
In the present investigation, we used 3-D models to test the possibility that increased PCa adhesion to bonederived ECM could promote PCa homing to bone. The objectives of this study were: 1) To investigate if RANKL overexpression promotes overexpression of integrins that support the adhesion of PCa cells to bone matrix proteins; 2) To determine if the levels of integrin expression are affected by growing PCa cells in 3-D suspension culture; 3) To determine if AR can be restored in RANKLoverexpressing LNCaP cells, and whether this restored AR modulates integrin expression/function to increase the growth, adhesion and survival of PCa cells in bone. To the best of our knowledge, we illustrated for the first time that overexpression of RANKL in human PCa cells induced dramatic upregulation of integrin α 2 expression which facilitated the adhesion of PCa cells, specifically to collagen type I (ColI). We assessed and compared the adhesion of PCa cells to ColI in 2-D vs. 3-D culture, and determined the roles of FAK and Akt activation in PCa adhesion and survival. We further assessed the overall effects of AP-4, a newly identified regulator of AR, on cell adhesion to ColI via increased α 2 integrin expression.
Results

Comparison of LNCaP
Neo and LNCaP RANKL cell adhesion, integrated motility, and migration
Previous studies established that RANKL-overexpressing LNCaP or ARCaP cells metastasized to bone and soft tissues when inoculated intracardially [11, 34] . We used the RANKL-transfected LNCaP cell line, LNCaP RANKL , to test the possibility that increased PCa cell homing to mouse skeleton could be due to increased cell adhesion and migration through a rise in integrin expression. We Figure S1 and Additional file 2: Table S1 . Based on these comparative studies, we concluded that 3-D suspension culture has the definitive advantages of simplicity, ease of expanding into large scale culture, low cost, and production of spheroid structures that can be easily handled for histopathologic and immunohistochemical analyses of the cultured cells. After these comparative studies, we compared the adhesion and migration of LNCaP Neo and LNCaP RANKL cells cultured in a 2-D monolayer rather than 3-D suspension. Figure 1A shows that LNCaP RANKL cells attached to the ColI and collagen IV (ColIV) extracellular matrices, better than LNCaP Neo cells. Results indicate that the higher adhesion of LNCaP RANKL cells to ColI-coated plates was further enhanced when they were pre-grown in 3-D suspension culture ( Figure 1A ; left panel). As expected, the increased adhesion of LNCaP RANKL cells to ColI can be antagonized by an anti-α 2 β 1 antibody, where a 55% reduction of cell adhesion to ColI was observed within 30 min In the left panel, RANKL expression is shown to enhance the adhesion of PCa cells to ColI. For each condition, 5,000 single cells from 2-D monolayer or 3-D suspension culture were seeded on 96-well plates pre-coated with ColI, ColIV or FN. After 30 minutes of incubation, the number of adherent cells was determined using alamarBlue assay. LNCaP RANKL cells preferentially adhered to ColI, especially when the cells were pre-conditioned in 3-D suspension culture. In the right panel, a similar assay was conducted with cells pre-conditioned in 3-D suspension culture, where antagonizing antibody to α 2 β 1 integrin was introduced to interfere with adhesion. The results are presented along with ratios to the control LNCaP Neo cells for each condition. Each data point is the mean ± SD of 6 measurements from 2 independent experiments. (B) Time lapse fluorescence microscopy was used to determine cell motility. Compared to control, motility of LNCaP RANKL cells was enhanced by 3 fold when the cells were pre-conditioned in 3-D suspension culture. Integrated distance traveled was normalized to LNCaP Neo cells and presented as the mean ± SD of 5 separate experiments. (C) Pre-conditioning in 3-D suspension culture increased the migration potential of LNCaP RANKL cells. In the upper left panels, cells in 2-D monolayer culture on ColI-coated plates were subjected to a wound healing assay. In the upper right panels, migration of cells pre-conditioned in 3-D suspension culture was assessed. In the lower panels, changes in cell migration were quantified based on the results of 3 separate experiments.
( Figure 1A ; right panel). We noted that LNCaP RANKL cells anchored to ColI much more rapidly (within 30 minutes) under 3-D suspension compared to growth in 2-D monolayer or compared to LNCaP Neo cells. The adhesion difference between the two cell lines and among different ECMs was not significant after 3 hours (Additional file 3: Figure S2 ). As illustrated, LNCaP RANKL cells also exhibited higher adhesive properties to ColIV but not to FN or plastic under suspension culture conditions. In sharp contrast, LNCaP Neo cells had no preferential binding to collagens (I and IV) under any of the culture conditions tested. The higher ColIV binding preference of LNCaP RANKL cells could explain their higher invasiveness through basement membranes compared to their parental control LNCaP Neo cells, as described previously [11] . Figure S3A ). Using microarray data, we also found that integrin α 2 expression in LNCaP RANKL cells was further enhanced by subjecting LNCaP RANKL cells to 3-D suspension culture (Additional file 4: Figure S3A ). mRNA and protein expression of integrin α 2 was performed in each condition and confirmed the microarray data (Figure 2A, 2B) . qRT-PCR analysis of cell embedded in suspension containing 0.1 mg/ml ColI suggests that higher expression of integrin α 2 in cells could be further triggered in the presence of ColI (Figure 2A This band could represent a soluble RANKL. In a parallel study using Elisa assay we have shown that soluble RANKL only increases by 7% in LNCaP Neo cells when compared 3-D suspension with 2-D monolayer. However, this difference increases to 30% in LNCaP RANKL cells. Higher soluble RANKL in 3-D suspension could be explained by potentially higher MMP7 expression in this condition, which is known to be responsible for the cleavage of RANKL [38] . Corresponding with the increased integrin α 2 , we also observed that LNCaP RANKL cells expressed higher levels of phosphorylated focal adhesion kinase (FAK) and phosphorylated Akt, when compared to 2-D monolayer ( Figure 2D ). Interestingly, under 3-D suspension conditions, LNCaP
Neo parental cells showed slightly lower p-FAK expression, while Akt phosphorylation was significantly higher. These data in aggregate suggest that RANKL-expressing PCa cells grown in 3-D suspension have elevated cell adhesion and survival capability and this is likely mediated by activated α 2 β 1 integrin.
Other ECM receptors have been shown to play a role in PCa invasion and migration including ColIV receptor, α 1 β 1 [39] , laminin receptors, α 3 β 1 [40] and α 6 β 1 [25] , and fibronectin receptor, α v β 3 [41] . We compared the microarray expression of α 1 , α 3 , α 6 , α v , β 1, and β 3 between LNCaP Neo and LNCaP RANKL cells. Other than increased integrin α 2 expression, only integrin α v β 3 showed significantly increased expression in 3-D suspension versus 2-D monolayer culture (Additional file 4: Figure S3A ). However, we could not confirm the differential expression of this integrin by FACS analysis (data not shown). Additionally, we analyzed the cell surface expression of integrin α 2 in the androgen-refractory PCa cancer cell line, ARCaP. Upon malignant progression, ARCaP M cells are known to express high endogenous RANKL [9] and fail to express functional AR [42] . ARCaP M cells were found to express lower levels of integrin α 2 than indolent ARCaP E cells (Additional file 4: Figure S3C ). ColI. LNCaP RANKL cells grown on 2-D monolayer or in 3-D suspension were treated with 10nM R1881, an androgen agonist, or 10 nM R1881 plus an AR antagonist, Casodex (Bicalutamide, 20nM). Cell adhesion to ColI was examined relative to plastic as a control. Under R1881 treatment, in either 2-D monolayer or 3-D suspension culture, LNCaP RANKL cell adhesion to ColI compared to plastic control was significantly higher by 4-and 9-fold, respectively. Casodex was found to block the adhesion of LNCaP RANKL cells to ColI by 1.3-fold in 3-D suspension culture. As expected, AR antagonist did not affect the ColI binding of LNCaP RANKL cells when grown in a 2-D monolayer because of the absence of detectable AR expression under this culture condition ( Figure 3D ). These results suggest that activated AR, in the presence of R1881 treatment, induces integrin α 2 expression and is responsible for the increased adhesion of LNCaP RANKL cells to a ColI substratum.
Restoration of AR expression in
Restoration of AR expression by downregulating transcription factor AP-4
Our previous publication using site-directed mutagenesis and transcription factor deletion/interference assays identified the suppressive action of AP-4 on AR expression [11] . We hypothesized that decreased AP-4 expression could contribute to increased AR expression in LNCaP RANKL cells with the synthetic androgen R1881 (10 nM, 48 hours), which resulted in significantly enhanced cell adhesion to ColI. On the other hand, the antagonistic effect of the anti-androgen casodex (20 nM) was seen mainly under 3-D suspension culture conditions. Each value is the mean ± SD of 2 independent experiments done in triplicate.
monolayer expressed higher AP-4 with corresponding lower AR. Upon AP-4 knockdown or in cells grown in 3-D suspension, AP-4 expression is reduced and this corresponds with increased AR expression ( Figure 4A, B) . AR restoration was confirmed by both Western blot and increased AR promoter luciferase activities ( Figure 4C, D) . In support of the above observations, we also showed that the restored AR was functional, capable of driving increased PSA-promoter luciferase activity by 1.6 fold ( Figure 4E ). In resemblance to AP-4 which induced EMT in colorectal cancer [44] , AP-4 siRNA transfected LNCaP RANKL cells exhibited mesenchymal-to-epithelial transition (MET), a reversal of EMT biomarker expression and decreased cell invasion (Additional file 5: Figure S4A 
Discussion
The bone environment is enriched with cytokines, growth factors, progenitor cells, and hematopoietic cells, providing a suitable metastatic microenvironment to promote PCa tumor cell adhesion, proliferation, migration, and survival. Despite this supportive microenvironment, cancer bone metastasis is a highly inefficient process and occurs infrequently in cancer patients [45] . However, 80% of all PCa metastatic lesions exist in the bone [4, 5] . To understand the interactions between the tumor and its microenvironment, we engineered an indolent human PCa cell line, LNCaP, with RANKL. We examined LNCaP RANKL and ARCaP M cells, which endogenously expressed a high level of RANKL, for their metastatic potential to bone and soft tissues. The results consistently showed that RANKL drives these cells to undergo EMT and assume many characteristics considered as metastatic cancer cell phenotypes, including the expression of mesenchymal and stem cell biomarkers, neuroendocrine and osteomimetic properties [46] , gaining the propensity for metastasis to bone and soft tissues in mice [11] . Further, Chu et al. [11] showed that RANKL protein administered by the intra-peritoneal route can induce prostate cancer bone colonization in mice, confirming the importance of the pathophysiological role of RANKL as both autocrine and paracrine factor. In this study, we specifically examined the effects of the RANKL-RANK mediated signal network that drives PCa cells to express selected integrin isotypes favoring their adhesion to collagens, known to be rich in the bone microenvironment. Our work reveals the importance of the 3-D culture environment that determines integrin expression via functional AR and ultimately affects the pathophysiology of PCa metastases. The pathophysiologic significance of our findings is depicted in Figure 5 . 1) RANKL/RANK signaling augments integrin α 2 expression in RANKL-transfected LNCaP cells but not in ARCaP cells overexpressing RANKL intrinsically (Figure 2 , Additional file 4: Figure S3 ). This observation could possibly be due to the nearly undetectable levels of AR expression in the ARCaP cell line [42] . This suggests that other cell surface receptors, such as discoldin domain receptors [47, 48] , glycoprotein VI receptor [49] , leukocyteassociated Ig-like receptor [50] or mannose receptor [51, 52] , could be downstream targets of the RANKmediated signal network that controls ARCaP M cell progression and metastasis by interacting with collagen matrices. 2) Consistent with the high bone metastatic behavior of LNCaP RANKL cells, we have shown for the first time that integrin α 2 expression is significantly enhanced in a 3-D suspension model in a RANKL-dependent manner (Figure 2 ). Exacerbated integrin α 2 expression increases the binding of these cells specifically to ColI, the most abundant bone matrix protein (Figure 1) (Figure 2 ). High expression of integrin α 2 in metastatic PCa and its important role in cell survival and adhesion in the bone microenvironment is supported by recent experimental and clinical publications [53, 54] . 3) Concomitant with enhanced integrin α 2 expression, we also observed that LNCaP RANKL cells grown in 3-D suspension exhibited elevated functional AR expression, a result not seen in 2-D monolayer culture (Figure 3) . It worth mentioning, while functional assay of AR on LNCaP RANKL cells showed 4.3 fold increases in 3-D suspension/ 2-D monolayer, the fold difference in AR protein level seemed to be higher. However, we would not expect a linear relationship between AR and its responsive promoter-reporter activity due largely to the efficiency of AR and its accessory transcriptional factors binding to the promoters and also the efficiency of the translational machinery of proteins in cells that ultimately determine the promoter reporter activity. Moreover, inhibition of AR nuclear translocation by Casodex treatment reduced LNCaP RANKL cell adhesion to ColI (Figure 3 ), suggesting that LNCaP RANKL cell adhesion through integrin α 2 is potentially AR-dependent. Our data are in agreement with those of Nagakawa et al. [23] who showed that integrin α 2 expression and ColI adhesion could be elevated by AR expression in an AR-transfected PCa cell line, DU145. In support of experimental studies, we used the publicly available human prostate cancer genome data listed in TCGA [55] , to confirm a direct correlation between mRNA expression of AR and integrin α 2 (Spearman's correlation = 0.60, N = 302). Therefore, the adhesion of PCa cells in the bone microenvironment could be enhanced by modulating AR expression and function. While our study and others suggest that AR could regulate integrin α 2 , we were unable to find evidence that integrin α 2 directly increases AR activity. Our studies of AR promoter did not reveal any binding sites for integrin α 2. However, further studies are required to finally conclude whether integrin α 2 could directly or indirectly regulate AR expression. 4) We further illustrated that AR restoration in LNCaP RANKL cells under 3-D suspension condition is at the transcriptional level via downregulation of a key TF repressor, AP-4 ( Figure 4) . AP-4 overexpression concerts the upregulation of c-Myc/Max in RANKL-overexpressing PCa cells [11] and drives EMT in colorectal cancer [44, 56] . Similarly, downregulation of AP-4 with a concomitant increased expression of AR and integrin α 2 in PCa cells results in the reversal of EMT and reduced PC invasion (Additional file 5: Figure S4 ). Because enhanced AR activity was frequently observed in clinically advanced PCa specimens [57, 58] , we hypothesize that enhanced AR expression in LNCaP RANKL tumors could enhance the adhesion and survival of LNCaP RANKL cells in mice. In agreement with clinical observations and the role of AP-4 downregulation, our preliminary data showed that LNCaP RANKL cells overexpressing AR did have enhanced growth when inoculated as subcutaneous tumor xenografts in mice (data not shown). Further in vivo studies are warranted to determine if AR expression in LNCaP RANKL cells could confer increased α 2 integrin expression and bone colonization through adhesion of PCa cells to collagen matrix in the skeleton.
Our work reveals the importance of the 3-D culture environment that determines integrin expression via functional AR and ultimately affects the pathophysiology of PCa metastases. Our significant findings are as follows: 1) The ability of PCa cells to adhere, survive and metastasize to bone could be masked by culturing PCa cells as a 2-D monolayer. We observed that RANKL-overexpressing PCa cells have barely detectable AR when cultured on plastic. When these cells were grown as 3-D suspensions or in mice, AR was found to be restored and to activate PSA promoter-luciferase activity. Additionally, we observed higher adhesion of LNCaP RANKL cells to ColI in an AR-dependent manner, most likely through increased expression of α 2 integrin. These results are consistent with the high levels of AR expression in clinical PCa bone metastasis specimens. 2) The TF repressor, AP-4, was found to be a negative regulator of AR at the transcriptional level and is modulated in a cell context-dependent manner. We speculate that AP-4 downregulation, epigenetically via promoter methylation or genetically via AP-4 regulators such as c-Myc, could play a decisive role in upregulating the levels of AR. This could profoundly control the responses of prostate tumors to androgen deprivation therapy. 3) Upregulation of integrin α 2 may be a common path for human PCa to develop castration resistance and bone metastasis. Balasubramaniam et al. recently studied BAF57, a component of the switching-defective and sucrose nonfermenting (SWI/SNF) chromatin-remodeling complex conglomerate [59] . They found that BAF57 deregulation circumvented androgen-mediated signaling, upregulated α 2 integrin expression, altered other SWI/SNF complex components at the α 2 integrin locus and conferred a prometastatic migratory advantage on PCa cells that could contribute to castration resistance and bone metastasis in patients [60] . Hall et al. [36] demonstrated experimentally that LNCaP cells selected for ColI binding exhibit higher integrin α 2 expression, become more adhesive and migratory in in vitro and acquire the capacity to grow within the bone compared to non-collagen binding parental cells. These results are in agreement with work of Colombel et al. [54] who showed that higher α 2 β 1 protein expression in primary PCa tissues correlates with bone metastasis. Additionally, Sottnik et al. [53] demonstrated elevation of α 2 β 1 protein level in PCa skeleton metastases when compared to primary site or soft tissue metastases. These data along with our observations (Figure 2 ) suggest that ColI can re-program cell fates by forcing the expression of α 2 . Ultimately, through a RANKL-and α 2 -mediated downstream signal network ColI can transdifferentiate or reprogram non-metastatic PCa cells to gain increased adhesion, growth and survival potential in the bone microenvironment. More work is needed to build clinically relevant alternative cell signaling network models that could improve cancer diagnosis and prognosis and offer targets for therapeutic intervention.
Conclusion
The survival of patients with skeletal metastasis is very poor and more efficient prevention therapies are urgently needed. Our understanding of the role of the RANKL/RANK and AR axes in cancer cell adhesion is evolving. Our study supports direct regulation of integrin α 2 and adhesion to ColI through RANKL/RANK signaling. Previous experimental and clinical studies in agreement with our data show the direct role of AR in ColI adhesion, possibly through integrin α 2 expression. Our findings suggest that increased integrin activity enhances bone adhesion in a RANKL/RANK and AR dependent manner. Since there are studies supporting the regulation of AR through cell-ECM interaction, it is plausible that a positive feedback loop between AR and integrin α 2 is induced under 3-D and in vivo conditions to support the growth and survival of PCa cells through activated p-FAK and p-Akt. We anticipate expanding the described 3-D suspension culture into co-culture models where relevant cancer cells and normal cells of different lineages can be constructed, studied and fully characterized. We believe that 3-D suspension culture and the co-culture of cancer cells with relevant cells in the tumor microenvironment could provide important additional insights into cancer plasticity and progression.
Materials and methods
Cell culture Cell lines and 2D culture conditions
LNCaP human prostate cancer progression models were established by our laboratory as previously described [61] . [34, 42] were maintained in T-medium (Invitrogen, Carlsbad, CA) supplemented with 10% FBS. MC3T3 cells (kindly provided by Dr. Neale Weitzmann, Emory University, Atlanta, GA) were maintained in DMEM supplemented by 10% FBS. All cells were incubated in 5% CO 2 atmosphere at 37°C.
3D culture conditions Hydrogel
Hydrogel was prepared using the HyStem Hydrogel kit (Glycosan BioSystem Inc. CA) according to the manufacturer's instructions. In brief, Hystem and Extralink solutions were prepared by dissolving the lyophilized solids in DG water under aseptic conditions (1% w/v). Extralink was added to the HyStem in 1:4 ratio. The final solution was then incubated for 10 min before encapsulating the cell pellet (10,000 cells/ ml). 200 μl of the final solution was then plated in ultra-low attachment 24-well plates (Sigma) within 20 min of encapsulation for full polymerization in the 37°C incubator for 30 min before adding 1 ml complete medium per well. Collagen type I (BD Biosciences, 100 mg/ml rat tail) was added to the cell pellet at the 0.1 or 0.3 mg/ml final concentration (PH 7.0) before encapsulation, when specified. Medium was changed every 3 days by removing 500 μl/well of the medium and replacing it with 500 μl of fresh complete medium.
Suspension
LNCaP
Neo and LNCaP RANKL cells, cultured on plastic, were trypsinized at the log phase, washed and resuspended to a final concentration of 20,000 cells/ml. One ml of the final solution was then plated in ultra-low attachment 24-well plates (Sigma). Cells were maintained in RPMI 1640 supplemented with 5% FBS, incubated in 5% CO 2 atmosphere at 37°C and observed up to 12 days to assess growth and morphology before harvest for additional analysis. For ColI embedded cells, 0.1 or 0.3 mg/ml of ColI was added to the cell pellet before adding the medium. Medium was changed every 3 days by removing 500 μl/well of the medium and replacing it with 500 μl of fresh complete medium.
Mesh
Poly (D,L-lactide-co-glycolide) (PLGA) fiber sheets (Mesh) were kindly provided by Dr. JurgenGroll, University Hospital, Würzburg, Germany [62] . Sheets 120 μm thick were trimmed to 8 mm circles using a disposable biopsy punch (Kia Medical, Inc) and placed in 48-well plates. Wells were washed with 70% EtOH and twice with 1X PBS. Plates were left under UV light for 30 min before use. LNCaP Neo and LNCaP RANKL cells were trypsinized at the log phase, washed and resuspended to a final concentration of 10,000 cells/ml. 500 μl of the final suspended cells were plated in each well and grown for 7 days before they were fixed or collected for further analysis. To study the ColI interaction with cells, mesh fibers were coated with 50 ng/ul of rat tail ColI (BD Biosciences).
Mouse osteoblast matrix (mOBM)
MC3T3-E14, mouse osteoblast precursor cells were grown on 12-well plates (VWR) for 10 days to beyond confluence. Cells were then treated with osteogenic medium (100 nmol/L dexamethasone, 10 mmol/L betaglycerophosphate, and 0.05 mmol/L L-ascorbic acid-2-phosphate) for an extra 3 weeks with medium changes every 4 days, and then decellularized using 20nM of sterilized ammonium hydroxide (NH 4 OH) for 30 min, and washed extensively prior to seeding the cells [35, 63] .
In vivo experiments
All animal procedures were performed according to an approved protocol from the Institutional Animal Care and Use Committee of Cedars-Sinai Medical Center. LN RANKL , LN RANKL-AR cells (2×10 6 cells/100 μl PBS) were inoculated subcutaneously in 4-week-old male nude mice (Taconic, Oxnard, CA). All mice were followed for total of 45 days. Tumor volume was measured every 3 days.
Microarray data analyses for AR and integrin α 2 gene signature
To identify potential correlations between AR and integrin α 2 in human samples, we used a dataset that primarily included adenocarcinoma prostate cancer samples, the Cancer Genome Atlas (TCGA) dataset (n = 336). Expression data for the TCGA dataset was downloaded from the TCGA data portal (http://www.cbioportal.org/ public-portal/index.do).
Cell morphology
Samples were fixed with 3.7% formaldehyde permeabilized with 0.2% Triton X-100 (Sigma) for 30 min and blocked with 5% Bovine Serum Albumin (BSA) (Sigma) for 1 hour. Samples were then washed with phosphate-buffered saline (PBS), pH 7.4 and incubated with 4′-6-diamidino-2-phenylindole (DAPI) (100 ng/ml, Invitrogen) and Alexa Fluor® 488 and 568 Phalloidin (4 μl/ml, Life Technologies) for 1 hr in the dark for nucleus and f-actin cytoskeleton staining, respectively. Phase-contrast images were then captured using Nikon Eclipse Ti (NIKON instruments Inc.). Organoids were placed on coverslip-bottom chambers (Lab-Tek) and fluorescent confocal images were captured using Leica TCS-SP5 Xconfocol microscopy (Leica Microsystems).
Microscopic live cell imaging and analyses
2×10
4 cells/ml were seeded on 12-well plates coated with 50 ng/μl or decellularized mOBM wells. A Nikon Eclipse Ti inverted microscope equipped with an automotive x-y-z stage was used for multiposition and perfect focus system time-lapse microscopy. An environmental chamber was used to maintain humidity, 5% CO 2 , and 37°C temperature. FITC and TRITC filters with a shutter control (Lamda SC, Smart Sutter Controller) and a CCD Head camera (Andor Technology) were used for fluorescent imaging. All imaging was performed using a 10× phase contrast (Nikon Plan Fluor Ph1) objective. All the images were also converted to TIF files for analysis of shape and integrated distanced traveled using CellProfiler 2.1.0 (Broad Institute, Boston, MA).
RNA isolation and quantitative real-time PCR (qRT-PCR)
Total RNA from cells was isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. RNA concentration was quantified using the Nanodrop-2000 (ThermoScientific). Samples with a 260/280 ratio higher than 1.8 were used for subsequent procedures. Complementary DNA (cDNA) was generated from 1 μg of total RNA using M-MLV reverse transcriptase (Promega, Madison, WI), as instructed. 20 ng of cDNA was subjected to PCR analyses using an AB 7500 Fast detection system (Applied Biosystems, Foster City, CA) at 95°C for 10 min and 40 cycles of 95°C for 30 sec, 60°C for 30 sec, and 72°C for 30 sec, followed by a dissociation curve. The sequences of all primers used are listed in Table 1 .
Western blot analysis
LNCaP
Neo and LNCaP RANKL cells were cultured in 6-well plates under 2-D monolayer conditions to 70% confluence or in 3-D suspension conditions for 7 days. The cells were then pelletized and washed with PBS before being lysed in RIPA buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris/HCl, 1 mM EDTA and 25 mM NaF) containing 1× protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Samples were then centrifuged and the supernatants collected and quantified using the Bradford Protein Assay (Thermo Fisher Scientific, Waltham, MA). 20 μg of cell lysate were resolved on 4-15% Bis-Tris gradient SDS-PAGE (BioRad, Hercules, CA), followed by transblotting onto nitrocellulose membrane (BioRad, Hercules, CA).
The membranes were blocked in 5% non-fat milk in TBST for one hour at room temperature (RT) and incubated with diluted primary antibodies in blocking buffer at 4°C overnight. The primary antibodies used were AR (1:500), integrin α 2 (1:500), β-actin 
Fluorescence Activated Cell Sorter (FACS)
LNCaP
Neo and LNCaP RANKL cells were detached from 2-D monolayer using accutase (Millipore) to preserve membrane receptors. Organoids from 3-D suspension culture were made into single cells using a final concentration of 1 mg/10 ml collagenase in accutase and 20 min incubation at 37°C. Cells were then washed and resuspended into single cell suspension in 1 × PBS containing 1% FBS (FACS buffer). After two washes with cold FACS buffer, cells were incubated for 30 min on ice with FITC-tagged anti-human CD49a, CD49b, CD51/61 and PE anti-human CD29 (BioLegend) or isotype control FITC mouse IgG1, k (eBioscience). Antibodies were washed twice with FACS buffer. Cell fluorescence signals were determined immediately after staining using a BD Accuri C6 flow cytometer (BD Biosciences) equipped with an argon laser emission of 488 nm. FITC and PE were identified using a 530 ± 15 nm and 585 ± 20 nm band pass filter, respectively. The analysis was performed using FlowJo software (TreeStar Inc.). A primary gate was set excluding dead cells or debris based on physical parameters (forward and side light scatter, FSC and SSC, respectively).
Adhesion assay
The adhesion assay was a modification of a previously published protocol [64] . For each condition, 1×10 5 cells/ml were placed in 15-ml conical tubes and 10 μg/ml α 2 β 1 blocking antibody (VLA-2 Millipro) or IgG 1 isotype control (bioLegend) was added and incubated for 20 minutes at room temperature. Binding assays were performed by seeding 5000 cells in 100 μl of complete medium on plastic or fibronectin-, collagen-IV-, or collagen I-precoated 96-well plates (BD Biosciences). At 30 min, 1-, 3-, 6-, 12-and 24-hr time points, wells were washed twice with PBS, 100 μl of complete medium was replaced, and 10 μlof alamarBlue (Invitrogen) was added, according to the manufacturer's instructions. After 12 hrs incubation at 37°C in the dark, the plates were read using the Spectra max M2 microplate reader (Molecular Devices, Sunnyvale, CA) at 590 nm with Softmax Pro software. All the readings were normalized to the reading of the well with no cells as a background measurement. The initial activity of the cells was measured by adding 10 μl of alamarBlue directly to the well without washing the cells.
For cells treated with R1881 and/or Casodex, serumstarved medium with 5% dextran-coated charcoal was used instead of complete medium. Plates were washed at 30 min and 1 hr time points and read after 12 hrs of alamaBlue assay. Each condition was performed in triplicate and two independent experiments were carried out per condition.
Immunohistochemical (IHC) analysis Sample preparation
IHC staining was applied to cells grown as in vitro 2-D monolayers. Cells were grown directly on 8-chamber slides to 80% confluence. In some cases, cells were grown as in vitro 3-D organoids. Organoids harvested from the 3-D suspension culture were carefully collected into 1.5 ml eppendorf tubes and spun down to a pellet. 1% LMP agarose solution was prepared and added to the pellet. After solidification, using a micro spatula, agarose-cell pellets were wrapped in tissue paper, placed in a plastic tissue cassette, and tissue processing was performed overnight using an automated tissue processor. For in vivo tissues, subcutaneous tumors were collected and fixed in 4% formaldehyde immediately for 24 hrs. The next day, tumors were processed for paraffin embedment as described above.
Histology analysis
IHC was followed according a previously published protocol [10] . All reagents from the DAKO system (Carpinteria, CA) were used for immunoperoxidase staining of the sectioned slides. Paraffin-embedded slides were rehydrated and antigenic epitopes were retrieved in citrate buffer using a pressure cooker. After antigen retrieval, slides were blocked with dual endogenous enzyme block (DEEB) at RT for 10 min and incubated with primary antibodies against AR (Santa Cruz) at 4°C overnight. The slides were placed at RT for 1 h, rinsed in Tris-buffered saline with 0.05% Tween (TBST) and incubated with Envision + Labeled Polymer-HRP at RT for 30 min. The slides were incubated with peroxidase substrate buffer with a chromogen, diaminobenzidine (DAB), to detect the staining signal, followed by hematoxylin counterstaining of nuclei. After dehydration and cover-slipping, the slides were examined by light microscopy. For monolayer samples, slides were blocked without the peroxidase step.
Transient transfection and luciferase reporter assays
AR [65] promoter-luciferase plasmid DNA and control CMV-TK plasmid DNA (for transfection efficiency control) were transiently transfected into prostate cancer cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) for 48 hrs. The cells were then harvested and protein lysate extracted using 1× passive lysis buffer (Promega, Madison, WI). The lysate was centrifuged at 13,200 rpm at 4°C for 10 min, and the supernatant was collected for luciferase assay. Promoter and TK activity was measured using Dual-Glo luciferase assay, as instructed (Promega, Madison, WI). In short, 20 μl of protein lysate was mixed with 100 μl of substrate (luciferin) and luciferase activity was measured using a BD Monolight 3010 luminometer (BD Pharmingen, San Diego, CA). TK activity was measured by immediately adding 100 μl of Stop&Glo buffer with 50× Stop&Glo substrate to the mix and re-measuring the samples. The relative luciferase activity of each sample was calculated by normalizing to the TK activity. To assess PSA [66] promoter-luciferase activity, we followed the same procedure as above. In addition, cells were serumstarved for 24 hrs before treatment with either 10 nM ethanol or R1881 for another 48 hrs before harvest. Each condition was done in quartet and two independent experiments were carried out per assay.
Migration and invasion assays
Cell migration and invasion analysis were performed in a 24-well plates using Transwell™ chambers (BD Biosciences). As described previously, transwells were coated with collagen type I or growth factor reduced Matrigel (BD Biosciences) for migration or invasion assay, respectively. LNCaP were serum-starved in RPMI 1640 overnight. The next day, transwells were placed on 24-well plates with 400 μl of complete medium. 100 μl of serum-free RPMI 1640 containing 5x10 4 cells were seeded inside the chambers for 24 hr (migration) or 48 hr (invasion) at 37°C. At each time point, cells remaining on the transwell were fixed with 10% formaldehyde and stained with 0.5% crystal violet. Cells inside the chamber were cleared and remaining cells where quantified [67] .
In vitro healing assay and 3D migration assay 24-well plates were coated with 50 ng/μl rat tail ColI and stored at 4°C overnight. Wells were washed twice with PBS before use. For the 2-D wound healing assay, cells were seeded in 24-well plates and cultured to 90% confluence. A straight scratch was made using a 1,000 μl pipette tip to simulate a wound. Wells were washed with 1X PBS to remove unattached cells. Wells were imaged at time zero and after 24 hrs using the 4× objective. Images were analyzed using ImageJ and the distanced traveled was measured. Three images were taken of each triplicate well for two independent experiments. For the 3-D migration assay, organoids were taken from 7-day suspension culture and placed on 24-well ColI-coated plates. Images were captured right after seeding and at 24, 48, and 72 hrs. The area covered by the cells was measured using ImageJ and compared between the two cell lines at each time point. The study was done in triplicate for two independent experiments.
Cell transfection and transduction protocol
LNCaP RANKL cells were grown in 6-well plates to 60% confluence, then transfected with 100 pmol final concentration of AP-4 siRNA or control siRNA (Santa Cruz Biotechnology, Inc.) for 48 hrs, using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Samples were collected for qRT-PCR and western blot analysis or further transfected with AR or PSA promoter for the luciferase promoter assay as described above.
For cell transduction, LNCaP RANKL cells were grown in 48-well plates to 50% confluence 24 hrs before transduction. Next day, the complete medium was replaced with complete medium containing Polybrene at a 5 μg/ml final concentration. Cells were infected with AP-4 or control sh-RNA lentiviral particles (Santa Cruz) for 24 hrs. Cells were cultured for an extra 24 hrs before being split to 1:3 ratio. Cell selection was started after an additional 24 hrs with 2 μg/ml of Puromycin.
Microarray analysis
RNA was isolated as above, hybridized to human U133plus2.0 array, and Affymetrix Gene Chip Expression Analysis was performed (UCLA Clinical Microarray Core). The microarray data was first preprocessed with quantile normalization. Genes were selected based on Students T-tests with P <0.05 and fold changes >2.
Statistical analysis
Differences between groups were analyzed using Student's t-test. A p-value < 0.05 was considered statistically significant (denoted by an asterisk). At least three independent in vitro experiments were conducted in triplicate for all assays and analyses, unless otherwise specified. Table S1 . Assessments of 3-D culture conditions. 2-D monolayer culture on plastic was compared with models of 3-D cultures in matrigel, hydrogel, Mesh, and in suspension. 3-D suspension culture was found to be superior in terms of biological relevance, sample production for further molecular analysis, time and cost efficiency, and ease of operation. 
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